Dmitri Dormeshkin

Years Active: 2022-2023
Publications (10 Years): 5

This page only lists publications with an associated author ORCID identifier.

Publications

Dmitri Dormeshkin, Mikalai Katsin, Maria Stegantseva, Sergey Golenchenko, Michail Shapira, Simon Dubovik, Dzmitry Lutskovich, Anton Kavaleuski, Alexander Meleshko
Design and Immunogenicity of SARS-CoV-2 DNA Vaccine Encoding RBD-PVXCP Fusion Protein. Vaccines 11 (6) (2023)
Dmitri Dormeshkin, Mikalai Katsin, Maria Stegantseva, Sergey Golenchenko, Michail Shapira, Simon Dubovik, Dzmitry Lutskovich, Anton Kavaleuski, Alexander Meleshko
Design and Immunogenicity of SARS-CoV-2 DNA Vaccine Encoding RBD-PVXCP Fusion Protein. Vaccines 11 (6) (2023)
Mikalai Katsin, Dmitri Dormeshkin, Alexander N Meleshko, Alexandr A Migas, Simon Dubovik, Natalya Konoplya
CAR-T Cell Therapy for Classical Hodgkin Lymphoma. HemaSphere 7 (12) (2023)
Dmitri Dormeshkin, Michail Shapira, Alena Karputs, Anton Kavaleuski, Ivan Kuzminski, Elena Stepanova, Andrei Gilep
Combining of synthetic VHH and immune scFv libraries for pregnancy-associated glycoproteins ELISA development. Applied microbiology and biotechnology 106 (13-16) (2022)
Alexander N Meleshko, Nadzeya Piatrouskaya, Katsiaryna Vashkevich, Dzmitry Lutskovich, Chuan Wang, Dmitri Dormeshkin, Natalia Savelyeva, Mikalai Katsin
Safety and Immunogenicity of Combined DNA-Polyethylenimine and Oral Bacterial Idiotypic Vaccine for Patients with B-Cell Non-Hodgkin Lymphoma: A Pilot Study. Cancers 14 (14) (2022)

Dmitri Dormeshkin.css-eqlu8i{font-size:small;padding-left:4px;}